Matches in Nanopublications for { ?s ?p "[We analyzed the methylation status of RASSF1A, BLU and SEMA3B in 35 hepatocellular carcinomas (HCCs) and 15 cholangiocarcinomas (CCs) by methylation-specific PCR and loss of heterozygosity (LOH) at 3p21.3 after microdissection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP487798.RAjLBxlTZomg6IdQbR65DD7uEMCGkIB1CCAHs7_ERKwsw130_assertion description "[We analyzed the methylation status of RASSF1A, BLU and SEMA3B in 35 hepatocellular carcinomas (HCCs) and 15 cholangiocarcinomas (CCs) by methylation-specific PCR and loss of heterozygosity (LOH) at 3p21.3 after microdissection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487798.RAjLBxlTZomg6IdQbR65DD7uEMCGkIB1CCAHs7_ERKwsw130_provenance.
- NP577105.RAvJ0WikNPtUooc7oCUHfcvJ8LF46KCW5zmt7kDL3Qjbw130_assertion description "[We analyzed the methylation status of RASSF1A, BLU and SEMA3B in 35 hepatocellular carcinomas (HCCs) and 15 cholangiocarcinomas (CCs) by methylation-specific PCR and loss of heterozygosity (LOH) at 3p21.3 after microdissection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577105.RAvJ0WikNPtUooc7oCUHfcvJ8LF46KCW5zmt7kDL3Qjbw130_provenance.
- NP714087.RA-qwurpbdG855VSE0ylulqiPpku8QmRASi1sfseQOM6Q130_assertion description "[We analyzed the methylation status of RASSF1A, BLU and SEMA3B in 35 hepatocellular carcinomas (HCCs) and 15 cholangiocarcinomas (CCs) by methylation-specific PCR and loss of heterozygosity (LOH) at 3p21.3 after microdissection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714087.RA-qwurpbdG855VSE0ylulqiPpku8QmRASi1sfseQOM6Q130_provenance.
- NP550790.RAJ4yAqAwBKa9GmOJeQ1XRAncm2VWd2nTEFpqJqFts-uk130_assertion description "[We analyzed the methylation status of RASSF1A, BLU and SEMA3B in 35 hepatocellular carcinomas (HCCs) and 15 cholangiocarcinomas (CCs) by methylation-specific PCR and loss of heterozygosity (LOH) at 3p21.3 after microdissection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP550790.RAJ4yAqAwBKa9GmOJeQ1XRAncm2VWd2nTEFpqJqFts-uk130_provenance.
- NP773919.RANvh5gdUHa9IR9BcnckacwjaFBRfXtjBhLTFKl3Lpsng130_assertion description "[We analyzed the methylation status of RASSF1A, BLU and SEMA3B in 35 hepatocellular carcinomas (HCCs) and 15 cholangiocarcinomas (CCs) by methylation-specific PCR and loss of heterozygosity (LOH) at 3p21.3 after microdissection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773919.RANvh5gdUHa9IR9BcnckacwjaFBRfXtjBhLTFKl3Lpsng130_provenance.
- NP785574.RAxqBSjKfZkoA4D1VRYr0COKK2PTsEZj_LN-9o5l1NApI130_assertion description "[We analyzed the methylation status of RASSF1A, BLU and SEMA3B in 35 hepatocellular carcinomas (HCCs) and 15 cholangiocarcinomas (CCs) by methylation-specific PCR and loss of heterozygosity (LOH) at 3p21.3 after microdissection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785574.RAxqBSjKfZkoA4D1VRYr0COKK2PTsEZj_LN-9o5l1NApI130_provenance.
- NP480317.RA-MNxG6LH0LkDzUvuzHsR8oda0UnU2E2JrC7eoGmW0VQ130_assertion description "[We analyzed the methylation status of RASSF1A, BLU and SEMA3B in 35 hepatocellular carcinomas (HCCs) and 15 cholangiocarcinomas (CCs) by methylation-specific PCR and loss of heterozygosity (LOH) at 3p21.3 after microdissection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480317.RA-MNxG6LH0LkDzUvuzHsR8oda0UnU2E2JrC7eoGmW0VQ130_provenance.